Cochlear Limited

Cochlear Limited is a leading global provider of implantable hearing solutions, specializing in cochlear implant systems, bone conduction devices, and sound processor upgrades. Headquartered in Sydney, Australia, the company has over 40 years of experience and holds approximately 60% of the global cochlear implant market share. Cochlear Limited serves both developed and emerging markets, with a strong focus on children and adults experiencing severe to profound hearing loss. Its products are distributed across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. Listed on the CHI-X Market Australia – Limit Venue, Cochlear Limited operates within the healthcare sector and is recognized for its innovation, robust financial performance, and significant contribution to improving hearing outcomes worldwide. The company’s shares are actively traded, reflecting its prominence in the medical technology industry.